AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 18 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $112,142,236 | -20.9% | 8,263,982 | 0.0% | 2.21% | -17.5% |
Q2 2023 | $141,727,291 | -15.0% | 8,263,982 | 0.0% | 2.68% | -29.1% |
Q1 2023 | $166,684,517 | -31.2% | 8,263,982 | 0.0% | 3.77% | -23.2% |
Q4 2022 | $242,134,673 | +76.7% | 8,263,982 | 0.0% | 4.91% | +68.0% |
Q3 2022 | $137,017,000 | +6.1% | 8,263,982 | 0.0% | 2.92% | -15.1% |
Q2 2022 | $129,166,000 | -14.7% | 8,263,982 | 0.0% | 3.44% | +4.2% |
Q1 2022 | $151,479,000 | +55.5% | 8,263,982 | 0.0% | 3.30% | +92.4% |
Q4 2021 | $97,432,000 | -43.8% | 8,263,982 | 0.0% | 1.72% | -28.5% |
Q3 2021 | $173,378,000 | -8.1% | 8,263,982 | 0.0% | 2.40% | -20.7% |
Q2 2021 | $188,667,000 | – | 8,263,982 | – | 3.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,758,686 | $78,857,000 | 4.67% |
RA Capital Management | 8,263,982 | $173,378,000 | 2.40% |
Cormorant Asset Management, LP | 2,030,691 | $41,962,000 | 1.70% |
SECTORAL ASSET MANAGEMENT INC | 341,367 | $7,162,000 | 0.60% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 714,285 | $14,986,000 | 0.29% |
Baker Brothers Advisors | 1,652,171 | $34,663,000 | 0.15% |
Old Well Partners, LLC | 12,600 | $264,000 | 0.14% |
Orbimed Advisors | 535,714 | $11,239,000 | 0.12% |
Parkwood LLC | 48,059 | $1,008,000 | 0.12% |
Darwin Global Management, Ltd. | 12,484 | $262,000 | 0.05% |